
Pharmaceuticals in Japan
Description
Pharmaceuticals in Japan
Summary
Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
- The Japanese pharmaceuticals market registered revenue of $94.3 billion in 2023, representing a compound annual growth rate (CAGR) of 7.3% between 2018 and 2023.
- Japan captured a share of 24.1% in the Asia-Pacific pharmaceuticals market, in 2023.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts
- What was the size of the Japan pharmaceuticals market by value in 2023?
- What will be the size of the Japan pharmaceuticals market in 2028?
- What factors are affecting the strength of competition in the Japan pharmaceuticals market?
- How has the market performed over the last five years?
- How large is Japan’s pharmaceuticals market in relation to its regional counterparts?
Table of Contents
48 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. Otsuka Holdings Co Ltd
- 8.2. Astellas Pharma Inc
- 8.3. Takeda Pharmaceutical Co Ltd
- 8.4. Daiichi Sankyo Co Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Japan pharmaceuticals market value: $ billion, 2018-23
- Table 2: Japan pharmaceuticals market geography segmentation: $ billion, 2023
- Table 3: Japan pharmaceuticals market value forecast: $ billion, 2023-28
- Table 4: Otsuka Holdings Co Ltd: Key Facts
- Table 5: Otsuka Holdings Co Ltd: Annual Financial Ratios
- Table 6: Otsuka Holdings Co Ltd: Key Employees
- Table 7: Otsuka Holdings Co Ltd: Key Employees Continued
- Table 8: Astellas Pharma Inc: Key Facts
- Table 9: Astellas Pharma Inc: Annual Financial Ratios
- Table 10: Astellas Pharma Inc: Key Employees
- Table 11: Takeda Pharmaceutical Co Ltd: Key Facts
- Table 12: Takeda Pharmaceutical Co Ltd: Annual Financial Ratios
- Table 13: Takeda Pharmaceutical Co Ltd: Key Employees
- Table 14: Takeda Pharmaceutical Co Ltd: Key Employees Continued
- Table 15: Daiichi Sankyo Co Ltd: Key Facts
- Table 16: Daiichi Sankyo Co Ltd: Annual Financial Ratios
- Table 17: Daiichi Sankyo Co Ltd: Key Employees
- Table 18: Daiichi Sankyo Co Ltd: Key Employees Continued
- Table 19: Daiichi Sankyo Co Ltd: Key Employees Continued
- Table 20: Japan Size of Population (million), 2019-23
- Table 21: Japan Real GDP (constant 2010 prices, $ billion), 2019-23
- Table 22: Japan GDP (current prices, $ billion), 2019-23
- Table 23: Japan Inflation, 2019-23
- Table 24: Japan Consumer Price Index (absolute), 2019-23
- Table 25: Japan Exchange Rate, 2018-23
- List of Figures
- Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
- Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.